Vismodegib
- Product Name
- Vismodegib
- CAS No.
- 879085-55-9
- Chemical Name
- Vismodegib
- Synonyms
- Vismodegib;GDC-0449;Erivedge;101098;CS-1913;RG 3616;Vimodji;VisModegib Base;Vismodegib 13C7;Vismodegib, >=99%
- CBNumber
- CB52500590
- Molecular Formula
- C19H14Cl2N2O3S
- Formula Weight
- 421.3
- MOL File
- 879085-55-9.mol
Vismodegib Property
- Melting point:
- 179-181°C
- Boiling point:
- 561.6±50.0 °C(Predicted)
- Density
- 1.440
- storage temp.
- -20°
- solubility
- Soluble in DMSO (up to 200 mg/ml) or in Ethanol (up to 10 mg/ml with warming)
- form
- White solid.
- pka
- 10.72±0.70(Predicted)
- color
- Off-white or beige
- Stability:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.
- InChI
- InChI=1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)
- InChIKey
- BPQMGSKTAYIVFO-UHFFFAOYSA-N
- SMILES
- C(NC1=CC=C(Cl)C(C2=NC=CC=C2)=C1)(=O)C1=CC=C(S(C)(=O)=O)C=C1Cl
Safety
- HS Code
- 29333990
- Hazardous Substances Data
- 879085-55-9(Hazardous Substances Data)
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Danger
- Hazard statements
-
H360May damage fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
- Precautionary statements
-
P260Do not breathe dust/fume/gas/mist/vapours/spray.
P273Avoid release to the environment.
P314Get medical advice/attention if you feel unwell.
P391Collect spillage. Hazardous to the aquatic environment
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- 13613
- Product name
- GDC-0449
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $75
- Updated
- 2021/12/16
- Product number
- 13613
- Product name
- GDC-0449
- Purity
- ≥98%
- Packaging
- 10mg
- Price
- $135
- Updated
- 2021/12/16
- Product number
- 13613
- Product name
- GDC-0449
- Purity
- ≥98%
- Packaging
- 50mg
- Price
- $338
- Updated
- 2021/12/16
- Product number
- 13613
- Product name
- GDC-0449
- Purity
- ≥98%
- Packaging
- 25mg
- Price
- $244
- Updated
- 2021/12/16
- Product number
- V674700
- Product name
- Vismodegib
- Packaging
- 50mg
- Price
- $375
- Updated
- 2021/12/16
Vismodegib Chemical Properties,Usage,Production
Description
In January 2012, the US FDA approved vismodegib (also referred to as GDC-0449) for the treatment of adults with metastatic basal cell carcinoma (BCC), with locally advanced BCC that has recurred following surgery or who are not candidates for surgery or radiation. Vismodegib inhibits the Hh sig?naling pathway by functioning as an antagonist of SMO thereby inhibiting the activation of Hedgehog target genes, resulting in decreased downstream pro?duction of proliferation factors. The IC50 of vismodegib in a Hedgehog?responsive cell line derived from human embryonic palatal mesenchyme cells was 2.8 nM. In preclinical in vivostudies, vismodegib at 12.5 mg/kg (bid) caused complete regression of tumors in a Hh pathway dependent medulloblas?tomaallograft model generated from Ptch+/-mice. A synthesis of vismodegib starting from 2-chloro-5-nitro aniline and employing a Negishi coupling with 2-pyridyl zinc iodide as a key step has been reported.
Chemical Properties
White Solid
Originator
Curis/Genentech (United States)
Uses
Vismodegib targets the Hedgehog (Hh) pathway. Inhibition of the Hh signaling may be effective in the treatment and prevention of many types of human cancers. Potent Hedgehog inhibitor.
Uses
Vismodegib (GDC-0449) is a potent, novel and specific hedgehog inhibitor with IC50 of 3 nM and also inhibits P-gp with IC50 of 3.0 μM.
Definition
ChEBI: A benzamide obtained by formal condensation between the carboxy group of 2-chloro-4-(methylsulfonyl)benzoic acid and the anilino group of 4-chloro-3-(pyridin-2-yl)aniline. Used for the treatment metastatic basal cell carcinoma.
brand name
Erivedge
Clinical Use
Antineoplastic agent:
Treatment of basal cell carcinoma which is inappropriate for surgery or radiotherapy
Synthesis
The synthesis began with selective iodination of commercial carboxylic acid 179, affording trisubstituted arene 180 in 73% yield. A Curtius reaction then converted 180 to carbamate 181 in 84% 52 yield, and this was followed by a palladium(0)-catalyzed borylation of 181 which furnished Suzuki coupling partner 182 in 91% yield. Pinacol borane 182 was exposed to commercial 2-bromopyridine under conventional cross-coupling conditions to furnish biaryl 183, which underwent Boc-deprotection in quantitative conversion to generate 184. Amide bond formation with acid chloride 185 (readily available from the corresponding commercial acid) produced vismodegib (XXVIII) in 99% yield.
target
Hedgehog
Drug interactions
Potentially hazardous interactions with other drugs
Antibacterials: concentration possibly reduced by
rifampicin - avoid.
Antidepressants: concentration possibly reduced by
St John’s wort - avoid.
Antiepileptics: concentration possibly reduced by
carbamazepine, fosphenytoin and phenytoin - avoid.
Antipsychotics: avoid with clozapine, increased risk
of agranulocytosis.
Metabolism
Vismodegib is hepatically metabolised by CYP2C9 and
CYP3A4, however more than 98
% of total systemic
vismodegib is not metabolised. Metabolic pathways
of vismodegib include oxidation, glucuronidation, and
pyridine ring cleavage. The two most abundant oxidative
metabolites recovered in faeces are produced in vitro by
recombinant CYP2C9 and CYP3A4/5.
Vismodegib is slowly eliminated by a combination of
metabolism and excretion of parent drug, the majority
is recovered in the faeces (82
%). Vismodegib and its
metabolites are eliminated mainly by the hepatic route.
storage
Store at -20°C
References
1) Rominger et al. (2009), Evidence for allosteric interactions of antagonist binding to the smoothened receptor; J. Pharmacol. Exp. Therap., 329 995 2) Tian et al. (2012), The hedgehog pathway inhibitor GDC-0449 alters intracellular Ca2+ homeostasis and inhibits cell growth in cisplatin-resistant lung cancer cells; Anticancer Res., 32 89 3) Zhang et al. (2009), Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp; Neoplasia, 11 96 4) Cirrone and Harris (2012), Vismodegib anf the hedgehog pathway: a new treatment for basal cell carcinoma; Clin. Ther., 34 2039 5) Wu et al. (2017), Smoothened antagonist GDC-0449 (Vismodegib) inhibits proliferation and triggers apoptosis in colon cancer cell lines; Exp. Ther. Med., 13 2529 6)Singh et al. (2011) Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms; PLoS One 6?e27306 7) Rudin et al. (2009) Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449; N. Engl. J. Med., 361?1173 8) Von Hoff et al. (2009) Inhibition of the hedgehog pathway in advanced basal-cell carcinoma; N. Engl. J. Med., 361?1164
Vismodegib Preparation Products And Raw materials
Raw materials
Preparation Products
Vismodegib Suppliers
- Tel
- 15011485209
- 17241816@qq.com
- Country
- China
- ProdList
- 81
- Advantage
- 58
- Tel
- 021-60441077 18701958033
- Fax
- 021-60441077
- shzxchem@163.com
- Country
- China
- ProdList
- 592
- Advantage
- 58
- Tel
- 17771424646
- shoubull@126.com
- Country
- China
- ProdList
- 969
- Advantage
- 58
- Tel
- 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9762
- Advantage
- 58
- Tel
- 13501719342
- wayne.zheng@elucigenbio.com
- Country
- China
- ProdList
- 5089
- Advantage
- 58
- Tel
- Fax
- 86-21-57758967
- sales@boylechem.com
- Country
- China
- ProdList
- 2922
- Advantage
- 55
- Tel
- 010-82848833 400-666-7788
- Fax
- 86-10-82849933
- jkinfo@jkchemical.com
- Country
- China
- ProdList
- 96815
- Advantage
- 76
- Tel
- +86-21-20908456
- Fax
- 021-58180499
- sales@BioChemBest.com
- Country
- China
- ProdList
- 6005
- Advantage
- 61
- Tel
- +86 (0) 571 85 58 67 18
- Fax
- 0086-571-85864795
- sales@capotchem.com
- Country
- China
- ProdList
- 18207
- Advantage
- 66
- Tel
- 13817811078
- Fax
- 86-021-50426522,50426273
- sales@jingyan-chemical.com
- Country
- China
- ProdList
- 9976
- Advantage
- 60
View Lastest Price from Vismodegib manufacturers
- Product
- Vismodegib 879085-55-9
- Price
- US $0.00/g
- Min. Order
- 1g
- Purity
- More Than 99%
- Supply Ability
- 100kg/Month
- Release date
- 2024-07-24
- Product
- vismodegib 879085-55-9
- Price
- US $0.00-0.00/g
- Min. Order
- 1g
- Purity
- 98%
- Supply Ability
- 10KG
- Release date
- 2023-12-14
- Product
- GDC-0449 879085-55-9
- Price
- US $73.00/mg
- Min. Order
- 1KG
- Purity
- 98%
- Supply Ability
- 50ton/Month
- Release date
- 2021-12-21